Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
293 participants
INTERVENTIONAL
2006-03-31
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotic Formula and Infant Growth
NCT01476397
The Effects on Growth and Tolerance of an Infant Formula Fed to Term Infants
NCT01897922
Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term
NCT00936637
Growth and Tolerance of a Partially Hydrolyzed Infant Formula
NCT05047978
Single Vs Multi-strain Probiotics for Preterm Neonates
NCT07296718
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
infant formula
1. hydrolyzed infant formula without probiotics
2. hydrolyzed infant formula with probiotics
3. hydrolyzed infant formula with probiotics
2
infant formula
1. hydrolyzed infant formula without probiotics
2. hydrolyzed infant formula with probiotics
3. hydrolyzed infant formula with probiotics
3
infant formula
1. hydrolyzed infant formula without probiotics
2. hydrolyzed infant formula with probiotics
3. hydrolyzed infant formula with probiotics
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
infant formula
1. hydrolyzed infant formula without probiotics
2. hydrolyzed infant formula with probiotics
3. hydrolyzed infant formula with probiotics
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Solely formula fed
* 14 days of age
Exclusion Criteria
* Evidence of formula intolerance
* Current illness
12 Days
16 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mead Johnson Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mead Johnson
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deolinda Scalabrin, MD
Role: STUDY_DIRECTOR
Mead Johnson Nutrition
References
Explore related publications, articles, or registry entries linked to this study.
Scalabrin DM, Johnston WH, Hoffman DR, P'Pool VL, Harris CL, Mitmesser SH. Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double-blind, controlled trial. Clin Pediatr (Phila). 2009 Sep;48(7):734-44. doi: 10.1177/0009922809332682. Epub 2009 Mar 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3369-5
Identifier Type: -
Identifier Source: secondary_id
3369-5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.